Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2004 March; 5(1): 1.
Published online 2009 November 27. doi:  10.1208/pt050103
PMCID: PMC2784846

Nondestructive and on-line monitoring of tablets using light-induced fluorescence technology


A system using light-induced fluorescence (LIF) technology was developed for rapid and nondestructive analysis of active pharmaceutical ingredients on tablet surfaces. Nonhomogenous tablets with defined layer of active ingredients were made by 3-Dimensional Printing technology to determine penetration depths of the light source and the resultant fluorescence responses. The LIF method of analysis showed penetration to depths of up to 3 mm into tablets. A correlation between LIF signals from analysis of tablet surfaces and the total drug content of the respective tablets was established. This method of surface analysis was verified with UV spectrometric methods for the total drug content of each respective tablet. The results from a small sample population of tablets made from both homogeneous and nonhomogeneous powder mixtures established good correlation between LIF surface monitoring and total tablet content. The use of on-line monitoring of the individual tablet for surface content demonstrated consistent LIF profiles from simulated production rates up to 3000 tablets a minute. The instrument was also field tested successfully on a tablet analyzer.

KeyWords: pharmaceuticals, tablets, surface analysis, production profile, PAT

Full Text

The Full Text of this article is available as a PDF (484K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Lai CK, Holt D, Leung JC, Raju GK, Hansen P, Cooney CL. Real-time and non-invasive monitoring of dry powder blend homogeneity. AIChE J. 2001;47:2618–2622. doi: 10.1002/aic.690471124. [Cross Ref]
2. Lai CK, Cooney CL. Application of a fluorescence sensor for mini scale online monitoring of powder mixing kinetics. J Pharm Sci. 2004;93:60–70. doi: 10.1002/jps.10478. [PubMed] [Cross Ref]
3. Udenfriend S. Fluorescence Assay in Biology and Medicine. New York, NY: Academic Press; 1969.
4. RxList: The Internet Drug Index Web site. Available at Accessed: [Please provide month], 2002.
5. Chrai SS, Singh B, Kopcha M, Murari R, Sun S, Kumar N, Desai N, Levine A, Rivenburg H, Kaganowicz G. Electrostatic dry deposition technology. Pharm Tech. 1998;April:106–110.
6. Katstra WE, Palazzolo RD, Rowe CW, Giritlioglu B, Teung P, Cima MJ. Oral dosage forms fabricated by Three Dimensional Printing. J Control Release. 2000;66:1–9. doi: 10.1016/S0168-3659(99)00225-4. [PubMed] [Cross Ref]
7. Rowe CW, Katstra WE, Palazzolo RD, Giritlioglu B, Teung P, Cima MJ. Multim echanism oral dosage forms fabricated by Three Dimensional Printing. J Control Release. 2000;66:11–17. doi: 10.1016/S0168-3659(99)00224-2. [PubMed] [Cross Ref]
8. Hargis LG. Molecular fluorescence spectroscopy. In: Hargis LG, editor. Analytical Chemistry—Principles and Techniques. Upper Saddle River, NJ: Prentice-Hall International Editions; 1988. pp. 436–437.
9. Murray M, Uraizee S, Sakr A. Preliminary investigations of the suitability of the USP uniformity of dosage units tests for evaluating the uniformity of powder blends and their corresponding tablets. Pharm Ind. 1995;57:256–262.
10. Ajaz Hussain. Draft Guidance for Industry PAT—A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance, Food and Drug Administration Web site. Available at: Accessed: [Please provide month], 2002.
11. Arrivo SM. The role of PAT in pharmaceutical research and development. J Am Pharm Rev. 2003;6:46–53.

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists